Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists identify bladder cancer genes in cats and dogs
Veterinary pathologists from 17 countries took part in the research.

The research could pave the way for new treatments.

An international team of scientists, working on human muscle-invasive bladder cancer (MIBC), has found the shared genes which play a role in cats and dogs spontaneously developing urothelial carcinoma (UC).

It is hoped the research will help identify which genes to target when developing treatments for human patients with bladder cancer. Previous sequencing had discovered around 60 genes which could have an influence on the development of human MIBC.

The results could also inform the development of therapies for cats and dogs.

The study, which involved veterinary pathologists from 17 countries, gathered bladder cancer tissue samples from human, canine, and feline patients and matched it with ‘healthy tissue’ to identify which genes had mutated.

Of the 60 genes which are known to mutate in human MIBC, three were found in cats (TP53, FAT1, and NRAS) and two in dogs (ARID1A and KDM6A). The feline gene which mutated most often, TP53, is also the same which most frequently mutates in human MIBC.

Similar genetic events, such as mismatch repair deficiency and chromothripsis, were also discovered in all three species.

The study, which involved researchers from institutions including the Wellcome Sanger Institute and the University of Guelph in Canada, is the most extensive sequencing of canine bladder cancer to date and the first-ever sequencing of feline bladder cancer.

Dr Louise van der Weyden, a senior author of the study, said: “This was a triumphant effort, pulling together veterinary pathologists from all over the world. It really is remarkable to have such diversity in tissue samples, thus we can be confident about the generalisability of our research.

“Our findings show it is good to have multiple animal models for bladder cancer biology representing different driver genes to capture distinct patient populations. We hope our findings will inform research in this area to help not only humans who get bladder cancer – but animals too, as therapies can benefit both species.”

 

Image (C) Shutterstock

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.